<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    SCYNEXIS, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About SCYNEXIS, Inc.

    SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by developing innovative therapies. The SCYNEXIS team has extensive experience in the life sciences industry, discovering and developing more than 30 innovative medicines over a broad range of therapeutic areas. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $84,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Marco Taglietti, M.D.
    • FOUNDED
      1999
    • EMPLOYEES
      20
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    DirectCare, Inc.

    DirectCare, Inc.

    Kumba Health is an online platform connecting doctors with patients. Kumba Health ...

    Kumba Health is an online platform connecting d...

    Fundraising Status:    SD
    Filing Type:    CF
    IRIDEX Corporation

    IRIDEX Corporation

    IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, ma...

    IRIDEX Corporation was founded in 1989 and is a...

    Filing Type:    PU
    Akcea Therapeutics, Inc.

    Akcea Therapeutics, Inc.

    Akcea Therapeutics is a development and commercialization company focused on helpi...

    Akcea Therapeutics is a development and commerc...

    Filing Type:    PU
    Quadrant Biosciences Inc

    Quadrant Biosciences Inc

    Quadrant Biosciences is an epigenetic diagnostics company with a focus on the earl...

    Quadrant Biosciences is an epigenetic diagnosti...

    Filing Type:    RA
    Robovet Corporation

    Robovet Corporation

    Robovet Corporation has developed a new MR imaging technology that can also help t...

    Robovet Corporation has developed a new MR imag...

    Amount Raised:    $136,889.00
    Fundraising Status:    EC
    Filing Type:    CF
    PolarityTE, Inc.

    PolarityTE, Inc.

    PolarityTE is a commercial-stage biotechnology and regenerative biomaterials compa...

    PolarityTE is a commercial-stage biotechnology ...

    Filing Type:    PU
    Biogen Inc.

    Biogen Inc.

    At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers...

    At Biogen, our mission is clear: we are pioneer...

    Filing Type:    PU
    Zimmerman BioPharma Holding, Inc.

    Zimmerman BioPharma Holding, Inc.

    ZBP is a biopharmaceutical company that has developed a proprietary technology to ...

    ZBP is a biopharmaceutical company that has dev...

    Fundraising Status:    EC
    Filing Type:    RA
    CNS Pharmaceuticals, Inc.

    CNS Pharmaceuticals, Inc.

    CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in ...

    CNS Pharmaceuticals is a pre-clinical stage bio...

    Amount Raised:    $628,558
    Fundraising Status:    EC
    Filing Type:    CF
    Spero Therapeutics, Inc.

    Spero Therapeutics, Inc.

    Spero Therapeutics, Inc. is a multi-asset, clinical-stage biopharmaceutical compan...

    Spero Therapeutics, Inc. is a multi-asset, clin...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.